Abnova (Taiwan) Corporation (TPE:4133)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.70
0.00 (0.00%)
Jun 18, 2026, 1:30 PM CST
Market Cap1.25B -29.9%
Revenue (ttm)348.71M -3.3%
Net Income1.92M -96.0%
EPS0.03 -96.2%
Shares Out 60.55M
PE Ratio652.84
Forward PEn/a
Dividend0.11 (0.54%)
Ex-Dividend DateJun 16, 2026
Volume102,283
Open20.70
Previous Close20.70
Day's Range20.60 - 20.85
52-Week Range20.35 - 29.15
Beta0.37
AnalystsHold
Price Target38.00 (+83.58%)
Earnings DateAug 13, 2026

About Abnova (Taiwan)

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company’s products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4133
Full Company Profile

Financial Performance

Financial Statements